Shionogi sees COVID pill reaping $2 billion in annual sales upon U.S. approval
Japan’s Shionogi & Co. believes its COVID-19 capsule will simply garner $2 billion in annual gross sales if it secures ...
Japan’s Shionogi & Co. believes its COVID-19 capsule will simply garner $2 billion in annual gross sales if it secures ...
Touch upon this storyRemarkRegardless of its livid response to Saudi Arabia’s choice final month to chop oil manufacturing within the ...
Copyright © 2022 Asia Today.